United States — Food and Drug Administration & Brazil

United States — Food and Drug Administration: The United States — Food and Drug Administration (FDA) approval is a critical milestone for Jyong Biotech's lead drug candidates, as it enables market access and sets a precedent for global regulatory pathways.

Brazil: Brazil is identified as a global market where FDA approval could accelerate regulatory pathways for Jyong Biotech's products.

United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.

Brazil: Brazil>>> is investigating suspected Ebola cases tied to travel from affected African nations. While initial tests for other diseases were positive, the possibility of Ebola has not been ruled out, creating uncertainty and potential for wider spread.